PAK6, a serine-threonine kinase belonging to the class II p21-activated kinase (PAK) family, is generally overexpressed or hyperactivated in multiple human cancers [69–72], and acts as an oncogene by promoting a number of cancer hallmarks including cancer initiation, cell growth, EMT, and metastasis [73, 74]. This evidence concerns the gene MARK2 and cancer.